• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Ancora Releases Presentation Highlighting the Opportunity for a Value-Maximizing, Competitive Sale Process at Ashland Inc.

    6/9/26 4:05:00 PM ET
    $ASH
    Specialty Chemicals
    Consumer Discretionary
    Get the next $ASH alert in real time by email

    Believes Ashland's High-Margin, Strategically Scarce Assets Are Being Undervalued by the Public Markets in the Face of Near-Term Growth and Execution Issues

    Urges Ashland's Board to Conduct a Full Review of Strategic Alternatives, Including Evaluating Sale Options Following Apparent Interest from Standard Industries as Well as Other Strategic and Private Equity Buyers

    Releases Presentation Outlining How a Sale Could Yield ~$76 Per Share or More, Representing a More Than 33% Premium and Likely the Best Risk-Adjusted Path Forward

    Ancora Holdings Group, LLC (collectively with its affiliates, "Ancora") today released a presentation (available here) detailing what it believes is a near-term opportunity to realize the intrinsic value of Ashland Inc. (NYSE:ASH) ("Ashland" or the "Company") through a sale of the Company. Ancora plans to engage in a constructive and open dialogue with Ashland to gauge the Board of Directors' willingness to evaluate the Company's standalone prospects versus a potentially value-maximizing sale to one of the many logical strategic or private equity acquirers in the space.

    Highlights of the presentation include:

    • Significant Mismatch Between Business Quality & Current Valuation: Ashland has the ultimate scarcity value of an established platform with diversified end market exposure, high-margin assets, long qualification cycles and high switching costs. The Life Sciences and Personal Care segments are Ashland's crown jewels, representing ~75%-80% of the Company's total EBITDA and generating stable EBITDA margins in the high-20s. These are differentiated, hard-to-displace ingredient businesses in resilient consumer end markets where Ashland holds both technology leadership and market share, providing the Company with deep customer relationships and product stickiness. Despite these fundamental strengths, the public markets continue to value Ashland at a conglomerate discount – the Company currently trades at ~9.6x EV/EBITDA, substantially below its historical median of ~11.0x and the ~13.8x median of comparable precedent transactions.
    • Existing Strategic Pressure: Chief Executive Officer Guillermo Novo transformed the business into a pure-play specialty chemical company during the first three years of his tenure via the sale of non-core assets, targeted cost rationalization efforts, deleveraging and share repurchases. However, the Company then pivoted to an investment-led organic growth strategy that has failed to deliver any volume benefits over the past three and a half years. Execution has deteriorated seemingly every quarter as Ashland has missed consensus estimates in four of the last five quarters. In the 24 hours following the disclosure of Ashland's disappointing 2Q26 earnings, the Company's share price fell by nearly 15%, demonstrating that investors have little confidence in Ashland's standalone path forward.1
    • Clear Path to a Competitive Sale Process: Standard Industries' investment arm already owns ~9.9% of the Company and has a history of accumulating small stakes before subsequently taking companies private, including W.R. Grace in 2021. Ancora's due diligence indicates there is also currently meaningful interest in Ashland from other potential strategic acquirers and sponsors, which could set the stage for a competitive process.
    • Potential for a Value-Maximizing Outcome: We estimate a take-out of Ashland could be executed at a base case 11.5x multiple, representing at least $76.47 per share or a 33.1% premium to the current share price.2 Our sum-of-the-parts valuation of $81.39 per share (41.6% upside) corroborates the take-out base case and provides an independent anchor for Ashland being fairly valued at above $80 during a competitive process.

    About Ancora

    Founded in 2003, Ancora Holdings Group, LLC offers integrated investment advisory, wealth management, retirement plan services and insurance solutions to individuals and institutions across the United States. The firm is a long-term supporter of union labor and has a history of working with union groups and public pension plans to deliver long-term value. Ancora's comprehensive service offering is complemented by a dedicated team that has the breadth of expertise and operational structure of a global institution, with the responsiveness and flexibility of a boutique firm. Ancora Alternatives is the alternative asset management division of Ancora Holdings Group, investing across three primary strategies: activism, multi-strategy and commodities. For more information about Ancora Alternatives, please visit www.ancoraalts.com.

    _________________

    1 FactSet. The Company's share price closed at $57.00 on 4/28/26 before it reported 2Q26 earnings after market close. The Company's share price closed at $49.15 on 4/29/26, the day following 2Q26 earnings,

    2 Company's share price was $57.46 as of 6/8/26 market close.

     

    View source version on businesswire.com: https://www.businesswire.com/news/home/20260609836160/en/

    Longacre Square Partners LLC

    ancora@longacresquare.com

    Get the next $ASH alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ASH

    DatePrice TargetRatingAnalyst
    5/6/2026$75.00Neutral → Buy
    Seaport Research Partners
    12/15/2025$71.00Market Perform → Outperform
    BMO Capital Markets
    9/8/2025$60.00Equal-Weight
    Morgan Stanley
    5/1/2025Overweight → Equal Weight
    Wells Fargo
    3/26/2025$68.00 → $71.00Neutral → Overweight
    Analyst
    3/5/2025Buy → Neutral
    Seaport Research Partners
    8/8/2024$90.00 → $89.00Underweight → Neutral
    JP Morgan
    4/11/2024$100.00 → $112.00Equal Weight → Overweight
    Wells Fargo
    More analyst ratings

    $ASH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Director Loy Bertrand

    4 - ASHLAND INC. (0001674862) (Issuer)

    5/18/26 4:32:03 PM ET
    $ASH
    Specialty Chemicals
    Consumer Discretionary

    SEC Form 3 filed by new insider Loy Bertrand

    3 - ASHLAND INC. (0001674862) (Issuer)

    5/18/26 4:30:07 PM ET
    $ASH
    Specialty Chemicals
    Consumer Discretionary

    SVP and GM, Personal Care Minicucci James P. exercised 4,310 shares at a strike of $55.01 and covered exercise/tax liability with 1,346 shares, increasing direct ownership by 70% to 7,221 units (SEC Form 4)

    4 - ASHLAND INC. (0001674862) (Issuer)

    5/11/26 4:30:04 PM ET
    $ASH
    Specialty Chemicals
    Consumer Discretionary

    $ASH
    SEC Filings

    View All

    SEC Form 11-K filed by Ashland Inc.

    11-K - ASHLAND INC. (0001674862) (Filer)

    6/17/26 3:45:14 PM ET
    $ASH
    Specialty Chemicals
    Consumer Discretionary

    SEC Form 11-K filed by Ashland Inc.

    11-K - ASHLAND INC. (0001674862) (Filer)

    6/17/26 3:44:23 PM ET
    $ASH
    Specialty Chemicals
    Consumer Discretionary

    SEC Form 11-K filed by Ashland Inc.

    11-K - ASHLAND INC. (0001674862) (Filer)

    6/17/26 3:40:16 PM ET
    $ASH
    Specialty Chemicals
    Consumer Discretionary

    $ASH
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    $ASH
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    $ASH
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Ashland upgraded by Seaport Research Partners with a new price target

    Seaport Research Partners upgraded Ashland from Neutral to Buy and set a new price target of $75.00

    5/6/26 7:31:43 AM ET
    $ASH
    Specialty Chemicals
    Consumer Discretionary

    Ashland upgraded by BMO Capital Markets with a new price target

    BMO Capital Markets upgraded Ashland from Market Perform to Outperform and set a new price target of $71.00

    12/15/25 8:56:16 AM ET
    $ASH
    Specialty Chemicals
    Consumer Discretionary

    Morgan Stanley initiated coverage on Ashland with a new price target

    Morgan Stanley initiated coverage of Ashland with a rating of Equal-Weight and set a new price target of $60.00

    9/8/25 8:48:38 AM ET
    $ASH
    Specialty Chemicals
    Consumer Discretionary

    Ashland responds to investor presentation by Ancora Alternatives LLC

    WILMINGTON, Del., June 10, 2026 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE:ASH) today issued the following statement in response to the investor presentation released by Ancora Alternatives LLC: Ashland's Board of Directors and management team are committed to driving sustainable value creation for all shareholders.  The Board recognizes and respects diverse perspectives and welcomes constructive input from shareholders.  While Ancora did not engage with Ashland prior to its presentation, Ashland intends to engage with Ancora in a manner consistent with that commitment as part of its ongoing dialogue with investors. Ashland remains focused on its growth strategies to execute, globalize, inno

    6/10/26 6:07:00 PM ET
    $ASH
    Specialty Chemicals
    Consumer Discretionary

    Ancora Releases Presentation Highlighting the Opportunity for a Value-Maximizing, Competitive Sale Process at Ashland Inc.

    Believes Ashland's High-Margin, Strategically Scarce Assets Are Being Undervalued by the Public Markets in the Face of Near-Term Growth and Execution Issues Urges Ashland's Board to Conduct a Full Review of Strategic Alternatives, Including Evaluating Sale Options Following Apparent Interest from Standard Industries as Well as Other Strategic and Private Equity Buyers Releases Presentation Outlining How a Sale Could Yield ~$76 Per Share or More, Representing a More Than 33% Premium and Likely the Best Risk-Adjusted Path Forward Ancora Holdings Group, LLC (collectively with its affiliates, "Ancora") today released a presentation (available here) detailing what it believes is a near-ter

    6/9/26 4:05:00 PM ET
    $ASH
    Specialty Chemicals
    Consumer Discretionary

    Ashland Board appoints Bertrand Loy as new director

    WILMINGTON, Del., May 18, 2026 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE:ASH) is announcing the appointment of Bertrand Loy to its board of directors, effective May 15, 2026. Loy currently serves as a director and the executive chair of Entegris Inc. (NASDAQ:ENTG), a leading supplier of advanced materials and process solutions for the semiconductor and high-technology industries and previously served as Entegris' president and chief executive officer. He will serve on the board's audit and governance and nominating committees, also effective as of May 15, 2026. With the addition of Loy and in anticipation of potential director retirements under the board's retirement and resignation policy,

    5/18/26 7:00:00 AM ET
    $ASH
    $ENTG
    Specialty Chemicals
    Consumer Discretionary
    Plastic Products
    Industrials

    Chair of the Board and CEO Novo Guillermo bought $2,010,327 worth of shares (31,294 units at $64.24) (SEC Form 4)

    4 - ASHLAND INC. (0001674862) (Issuer)

    2/3/25 4:30:05 PM ET
    $ASH
    Specialty Chemicals
    Consumer Discretionary

    SVP and GM, Life Sciences Assis Alessandra Faccin bought $201,600 worth of shares (3,150 units at $64.00) (SEC Form 4)

    4 - ASHLAND INC. (0001674862) (Issuer)

    2/3/25 4:30:03 PM ET
    $ASH
    Specialty Chemicals
    Consumer Discretionary

    $ASH
    Leadership Updates

    Live Leadership Updates

    View All

    Ashland Board appoints Bertrand Loy as new director

    WILMINGTON, Del., May 18, 2026 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE:ASH) is announcing the appointment of Bertrand Loy to its board of directors, effective May 15, 2026. Loy currently serves as a director and the executive chair of Entegris Inc. (NASDAQ:ENTG), a leading supplier of advanced materials and process solutions for the semiconductor and high-technology industries and previously served as Entegris' president and chief executive officer. He will serve on the board's audit and governance and nominating committees, also effective as of May 15, 2026. With the addition of Loy and in anticipation of potential director retirements under the board's retirement and resignation policy,

    5/18/26 7:00:00 AM ET
    $ASH
    $ENTG
    Specialty Chemicals
    Consumer Discretionary
    Plastic Products
    Industrials

    Ashland announces executive leadership changes

    WILMINGTON, Del., May 05, 2025 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE:ASH) announced today that Kevin Willis, senior vice president and chief financial officer, has decided to leave Ashland to pursue another opportunity. His last day with the company will be May 16, 2025. Willis joined Ashland in 1987 as an associate auditor in the internal audit department. He has served in various management positions of increasing responsibility, including leading teams on major projects in the business services, information technology, accounting and finance areas. Willis' departure is not the result of any disagreement with the company related to its financial statements, internal control over finan

    5/5/25 5:00:00 PM ET
    $ASH
    Specialty Chemicals
    Consumer Discretionary

    Turnspire Capital Partners Completes Acquisition of Pharmachem from Ashland

    Turnspire Capital Partners LLC ("Turnspire") announced today that an affiliate has completed the acquisition of Pharmachem Innovations, LLC ("Pharmachem" or the "Company"), the former nutraceuticals business of Ashland Inc. (NYSE:ASH). Additionally, Turnspire Operating Partner Maurice Murphy has been appointed Executive Chairman, and Jeff Rogers has been appointed Interim Chief Executive Officer of Pharmachem. Pharmachem is a leading provider of proprietary nutrition ingredients and custom formulation services that supplies a broad portfolio of both active ingredients and formulation aids to nutritional product companies. The Company also offers custom formulation and contract manufactu

    9/3/24 7:00:00 AM ET
    $ASH
    Specialty Chemicals
    Consumer Discretionary

    $ASH
    Financials

    Live finance-specific insights

    View All

    Ancora Releases Presentation Highlighting the Opportunity for a Value-Maximizing, Competitive Sale Process at Ashland Inc.

    Believes Ashland's High-Margin, Strategically Scarce Assets Are Being Undervalued by the Public Markets in the Face of Near-Term Growth and Execution Issues Urges Ashland's Board to Conduct a Full Review of Strategic Alternatives, Including Evaluating Sale Options Following Apparent Interest from Standard Industries as Well as Other Strategic and Private Equity Buyers Releases Presentation Outlining How a Sale Could Yield ~$76 Per Share or More, Representing a More Than 33% Premium and Likely the Best Risk-Adjusted Path Forward Ancora Holdings Group, LLC (collectively with its affiliates, "Ancora") today released a presentation (available here) detailing what it believes is a near-ter

    6/9/26 4:05:00 PM ET
    $ASH
    Specialty Chemicals
    Consumer Discretionary

    Ashland board authorizes quarterly dividend

    WILMINGTON, Del., May 05, 2026 (GLOBE NEWSWIRE) -- The board of directors of Ashland Inc. (NYSE:ASH) has declared a quarterly cash dividend of $0.42 cents per share on the company's common stock which represents a 1.2 percent increase from the previous quarter. The dividend will be payable on June 15, 2026, to stockholders of record at the close of business on June 1, 2026. As of April 30, 2026, there were 45,788,007 shares of Ashland common stock outstanding. About Ashland Ashland Inc. (NYSE:ASH) is a global additives and specialty ingredients company with a conscious and proactive mindset for environmental, social and governance (ESG). The company serves customers in a wide range of co

    5/5/26 5:01:00 PM ET
    $ASH
    Specialty Chemicals
    Consumer Discretionary

    Ashland reports second quarter fiscal 2026 results and updates full-year outlook

    Sales of $482 million, up one percent from the prior-year quarterIncome from continuing operations of $15 million, or $0.32 per diluted shareAdjusted Income from Continuing Operations Excluding Intangibles Amortization Expense of $42 million, or $0.91 per diluted shareNet income of $16 million, or $0.34 per diluted shareAdjusted EBITDA of $98 million, down nine percent from the prior-year quarter, primarily reflecting temporary operational impacts from the Calvert City startup delay, Hopewell productivity challenges, and weather-related disruptions in the second quarterCash flows provided by operating activities of $50 million; Ongoing Free Cash Flow2 of $29 millionUpdating full‑year fiscal

    4/28/26 5:01:00 PM ET
    $ASH
    Specialty Chemicals
    Consumer Discretionary

    $ASH
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Ashland Inc.

    SC 13G - ASHLAND INC. (0001674862) (Subject)

    11/12/24 11:54:03 AM ET
    $ASH
    Specialty Chemicals
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by Ashland Inc.

    SC 13G/A - ASHLAND INC. (0001674862) (Subject)

    7/10/24 1:14:41 PM ET
    $ASH
    Specialty Chemicals
    Consumer Discretionary

    SEC Form SC 13D/A filed by Ashland Inc. (Amendment)

    SC 13D/A - ASHLAND INC. (0001674862) (Subject)

    4/25/24 4:15:12 PM ET
    $ASH
    Specialty Chemicals
    Consumer Discretionary